Protagonist Therapeutics’ drug rusfertide reduced the need for phlebotomies as a way to treat the rare blood cancer polycythemia vera. Longer-term Phase 3 data for the Takeda Pharmaceutical-partnered peptide drug were presented during the annual meeting of the American Society of Hematology. The post Shining Light on How Protagonist, Takeda Drug Brings Treatment of a…
At a time when people are questioning not just their bills but the institutions that send them, trust is the currency that matters most. The post ‘Deductible Season’ Dilemma: Do Patients Really Need to Pay Those Past Due Bills? appeared first on MedCity News.
CMS is proposing major changes to Medicare Advantage Star Ratings, drawing mixed reactions from healthcare leaders. The post What Do Healthcare Leaders Think About CMS’ Proposed Star Ratings Overhaul? appeared first on MedCity News.
Instead of viewing obesity as one uniform condition, experts now recognize that it can arise from multiple biological patterns. Understanding that difference could finally change how we approach treatment altogether. The post It’s the End Of the Line for One‑Size‑Fits‑All Weight Loss appeared first on MedCity News.
A bipartisan Senate bill would boost transparency and oversight of pharmacy benefit managers by changing how they’re paid, expanding reporting requirements and strengthening protections for pharmacies and taxpayers. The post Senators Introduce Bipartisan Bill to Increase Oversight of PBMs appeared first on MedCity News.
As it deepens its push into healthcare, LG is developing more tools and workstations aimed at supporting clinical workflows. National sales leader Jim Salamon said the company’s innovations are designed around clinician needs, such as the desire for more lifelike color representation and lightweight displays that can be set up easily for home use. The…
Freenome’s SPAC merger agreement comes as the liquid biopsy developer prepares for potential 2026 commercialization of SimpleScreen, a colorectal cancer test currently under FDA review. If approved, the Freenome blood test would compete against Guardant Health’s liquid biopsy, Shield. The post Liquid Biopsy Firm Freenome Finds a Way to the Public Markets via $330M SPAC…
By building skills in operations and developing a close-knit team who show up to work with hearts of empathy and tenacity to problem solve, the issues become fewer and further between. The post Call Center Lessons: Streamline the Challenges and Celebrate More Wins appeared first on MedCity News.
Open enrollment 2026 marks a turning point in U.S. healthcare. The cost pressures are no longer cyclical; they are structural. For payers and providers alike, the challenge is clear: we must modernize operations, not just manage costs. The post Open Enrollment: Why Rising Premiums Are Forcing Healthcare Organizations to Bet on AI and Automation appeared…
At Forbes Healthcare Summit, Epic CEO Judy Faulkner explained why the company’s long-protected independence and unconventional management approach have been central to its dominance as an EHR vendor. Now, she says the company’s future will depends on how it uses its massive data stores to support AI-powered clinical decisions. The post Why Epic’s Judy Faulkner…